Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

E 10A

Next Previous
Drug Profile

E 10A

Alternative Names: Ad5-E10A; E10A

Latest Information Update: 11 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Guangzhou Double Bioproducts
  • Developer Guangzhou Double Bioproducts; Sun Yat-Sen University
  • Class Antineoplastics; Eye disorder therapies; Gene therapies
  • Mechanism of Action Endostatin replacements; Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Squamous cell cancer

Most Recent Events

  • 11 Oct 2021 No development reported - Phase-II for Squamous cell cancer (Combination therapy) in China (Intratumoural)
  • 11 Oct 2018 E 10A is still in phase III trials for Squamous cell cancer (Combination therapy, Metastatic disease, Late-stage disease) in China (Intratumoural)
  • 10 Oct 2018 No recent reports on development identified - phase III for Squamous cell cancer (Combination therapy, Metastatic disease, Late-stage disease) in China (Intratumoural)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top